PROSPERI DAVIDE

Ochoa, E., Morelli, L., Salvioni, L., Giustra, M., De Santes, B., Spena, F., et al. (2024). Co-processed materials testing as excipients to produce Orally Disintegrating Tablets (ODT) using binder jet 3D-printing technology. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 194(January 2024), 85-94 [10.1016/j.ejpb.2023.11.023]. Dettaglio

Morelli, L., Ochoa, E., Salvioni, L., Davide Giustra, M., De Santes, B., Spena, F., et al. (2024). Microfluidic nanoparticle synthesis for oral solid dosage forms: A step toward clinical transition processes. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 652(5 March 2024) [10.1016/j.ijpharm.2024.123850]. Dettaglio

Sevieri, M., Mazzucchelli, S., Barbieri, L., Garbujo, S., Carelli, S., Bonizzi, A., et al. (2023). Ferritin nanoconjugates guide trastuzumab brain delivery to promote an antitumor response in murine HER2 + breast cancer brain metastasis. PHARMACOLOGICAL RESEARCH, 196(October 2023), 1-12 [10.1016/j.phrs.2023.106934]. Dettaglio

Del Nero, M., Colombo, A., Garbujo, S., Baioni, C., Barbieri, L., Innocenti, M., et al. (2023). Advanced Cell Culture Models Illuminate the Interplay between Mammary Tumor Cells and Activated Fibroblasts. CANCERS, 15(9) [10.3390/cancers15092498]. Dettaglio

Rotem, R., Bertolini, J., Salvioni, L., Barbieri, L., Rizzuto, M., Tinelli, V., et al. (2023). Direct quantification of cytosolic delivery of drug nanocarriers using FlAsH-EDT2. NANOMEDICINE, 47(January 2023) [10.1016/j.nano.2022.102626]. Dettaglio